Pyrazinamide recalls

The FDA has published 2 recalls involving Pyrazinamide since 2022. The latest was reported on 24 May 2023. Most were for manufacturing (cgmp) deviations. RemedyRepack has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2022

Last 12 months0reported

Class I00% of total

Ongoing1latest 24 May 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why pyrazinamide is recalled

Manufacturing (CGMP) Deviations2100%

Companies

RemedyRepack150%
ANI Pharmaceuticals150%

By year

2023150%
2022150%

Ongoing pyrazinamide recalls

1 active

Reported	Class	Recall	Company	Reason	Where
24 May 2023Drug	CLASS II	Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card recalled	RemedyRepack	Manufacturing (CGMP) Deviations	PA

All pyrazinamide recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
24 May 2023Drug	CLASS II	Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card recalled	RemedyRepack	Manufacturing (CGMP) Deviations	PA
23 Feb 2022Drug	CLASS II	Pyrazinamide Tablets, USP 500 mg recalled by ANI Pharmaceuticals	ANI Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Pyrazinamide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.